speb/financial-data huggingface dataset:
SCI.NS income_statement (annual, 2025-03-31) — +Operating Expense: 1676500000.00
SCI.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 839100000.00
SCI.NS income_statement (annual, 2025-03-31) — +Total Revenue: 56058300000.00
SCI.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 13251900000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 8077400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 8077400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 11928700000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 11928700000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -68089600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -68089600000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 5217700000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 5217700000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -4001900000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -4001900000.00
SCI.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 2400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 0.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 0.00
SCI.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 175900000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 175900000.00
SCI.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 465808945.00
SCI.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 466347607.00
SCI.NS income_statement (annual, 2025-03-31) — Basic EPS: 18.11
SCI.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 3.97
SCI.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 8416200000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 205400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 205400000.00
SCI.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -2919200000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 2941200000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2941200000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 4658000000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 4658000000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 1357100000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1357100000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 13716100000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 13716100000.00
SCI.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -232100000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 993500000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 993500000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 363600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 363600000.00
SCI.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -186500000.00
SCI.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -6818400000.00
SCI.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 793200000.00
SCI.NS cash_flow (annual, 2025-03-31) — Change In Payable: -5479500000.00
SCI.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 1386200000.00
SCI.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -10305000000.00
SCI.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -7020300000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Common Stock: 4658000000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 4658000000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 83117400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 83117400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 43500000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 43500000.00
SCI.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 46252200000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 11193300000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Current Assets: 35748500000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 35748500000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 1117300000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1117300000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Current Debt: 4253400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 4253400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 5370700000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 5370700000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 16291100000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 16291100000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 89200000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 89200000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Defined Pension Benefit: 956600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Defined Pension Benefit: 956600000.00
SCI.NS cash_flow (annual, 2025-03-31) — Depreciation: 9513200000.00
SCI.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 9513200000.00
SCI.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 465808945.00
SCI.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 466347607.00
SCI.NS income_statement (annual, 2025-03-31) — Diluted EPS: 18.11
SCI.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 3.97
SCI.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 8435800000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1851400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 3000000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 3000000.00
SCI.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 467900000.00
SCI.NS income_statement (annual, 2025-03-31) — EBIT: 10381200000.00
SCI.NS income_statement (quarterly, 2025-03-31) — EBIT: 2101500000.00
SCI.NS income_statement (annual, 2025-03-31) — EBITDA: 19894400000.00
SCI.NS income_statement (quarterly, 2025-03-31) — EBITDA: 2101500000.00
SCI.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 500000.00
SCI.NS cash_flow (annual, 2025-03-31) — End Cash Position: 1396400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 53600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 53600000.00
SCI.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -12355700000.00
SCI.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 5575900000.00
SCI.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -561700000.00
SCI.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
SCI.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 48200000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 5400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 5400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 15930600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 15930600000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 135241500000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 67151900000.00
SCI.NS income_statement (annual, 2025-03-31) — Gross Profit: 9806100000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 2058600000.00
SCI.NS income_statement (annual, 2025-03-31) — Interest Expense: 1863300000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 388100000.00
SCI.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 1863300000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 388100000.00
SCI.NS income_statement (annual, 2025-03-31) — Interest Income: 934900000.00
SCI.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 934900000.00
SCI.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -1267000000.00
SCI.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 634400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Inventory: 1927600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 1927600000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 102461100000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 102461100000.00
SCI.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -3159700000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 53600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 53600000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Investmentsin Joint Venturesat Cost: 6448400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 6448400000.00
SCI.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 0.00
SCI.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 41900000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 41900000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 1823900000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 1823900000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 15090300000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 15090300000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 16914200000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 16914200000.00
SCI.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 0.00
SCI.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -7399200000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 6448400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 6448400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 662600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 662600000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 134950700000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 134950700000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Net Debt: 17986600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 17986600000.00
SCI.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 139800000.00
SCI.NS income_statement (annual, 2025-03-31) — Net Income: 8435800000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Net Income: 1851400000.00
SCI.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 8435800000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1851400000.00
SCI.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 8435800000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1851400000.00
SCI.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 8435800000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1851400000.00
SCI.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 8435800000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1851400000.00
SCI.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 8517900000.00
SCI.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 8435800000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1851400000.00
SCI.NS income_statement (annual, 2025-03-31) — Net Interest Income: -1863300000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -388100000.00
SCI.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -1352500000.00
SCI.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -10087700000.00
SCI.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -7399200000.00
SCI.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -1863300000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -388100000.00
SCI.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -154100000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Net PPE: 67151900000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 67151900000.00
SCI.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -2919200000.00
SCI.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -2688500000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 83112000000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 83112000000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 2400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 2400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 7600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 7600000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 662600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 662600000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 219700000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 219700000.00
SCI.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 19894400000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 2101500000.00
SCI.NS income_statement (annual, 2025-03-31) — Normalized Income: 8435800000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 1851400000.00
SCI.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 8495100000.00
SCI.NS income_statement (annual, 2025-03-31) — Operating Income: 8129600000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Operating Income: 1219500000.00
SCI.NS income_statement (annual, 2025-03-31) — Operating Revenue: 56058300000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 13251900000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 465799010.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 465799010.00
SCI.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 900000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 900000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 731000000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 731000000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 78459500000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 78459500000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 5400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 5400000.00
SCI.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 929800000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 74600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 74600000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 900000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 900000.00
SCI.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 1945300000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 753600000.00
SCI.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 1676500000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 839100000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Other Payable: 409500000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 409500000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Other Properties: 67108400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 67108400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 4651600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 4651600000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 12359000000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 12359000000.00
SCI.NS income_statement (annual, 2025-03-31) — Other Special Charges: -167600000.00
SCI.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
SCI.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
SCI.NS balance_sheet (annual, 2025-03-31) — Payables: 8489900000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Payables: 8489900000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1107800000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1107800000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 965900000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 965900000.00
SCI.NS income_statement (annual, 2025-03-31) — Pretax Income: 8517900000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 1713400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
SCI.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 530900000.00
SCI.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -1757800000.00
SCI.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -2919200000.00
SCI.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 46252200000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 11193300000.00
SCI.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 9513200000.00
SCI.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 48200000.00
SCI.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 1800600000.00
SCI.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -7399200000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 1680400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1680400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 17667800000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 17667800000.00
SCI.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 405300000.00
SCI.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 0.00
SCI.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 7200000.00
SCI.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 55400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Share Issued: 465799010.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 465799010.00
SCI.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
SCI.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
SCI.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 83117400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 83117400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 83112000000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 83112000000.00
SCI.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SCI.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SCI.NS income_statement (annual, 2025-03-31) — Tax Provision: 82100000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -138000000.00
SCI.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.01
SCI.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
SCI.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 877300000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 877300000.00
SCI.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: 6100000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Total Assets: 117010600000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 117010600000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 98207700000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 98207700000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Total Debt: 22284900000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 22284900000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 83117400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 83117400000.00
SCI.NS income_statement (annual, 2025-03-31) — Total Expenses: 46879200000.00
SCI.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 12032400000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 33893200000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 33893200000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 81262100000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 81262100000.00
SCI.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 17602100000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 17602100000.00
SCI.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 49200000.00
SCI.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
SCI.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
SCI.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
SCI.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
SCI.NS balance_sheet (annual, 2025-03-31) — Working Capital: 19457400000.00
SCI.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 19457400000.00
SCI.NS income_statement (annual, 2025-03-31) — Write Off: 24000000.00
SCI.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 103100000.00
SCI.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 13160400000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 466013158.00
SCI.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 7.60
SCI.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 10663900000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 466013158.00
SCI.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 7.60
SCI.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 3541700000.00
SCI.NS income_statement (quarterly, 2025-06-30) — EBIT: 3967900000.00
SCI.NS income_statement (quarterly, 2025-06-30) — EBITDA: 3967900000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 2496500000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 305200000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 305200000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Net Income: 3541700000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 3541700000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 3541700000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 3541700000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 3541700000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 3541700000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -305200000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -305200000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 3967900000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 3541700000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Operating Income: 2393400000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 13160400000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1463500000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 103100000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
SCI.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 3662700000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 10663900000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
SCI.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
SCI.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 121000000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.03
SCI.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 10767000000.00
SCI.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
SCI.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
SCI.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1172100000.00
SCI.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 13388700000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 8622400000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 12167200000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 0.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 238300000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 465911330.00
SCI.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 4.06
SCI.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2492100000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 4658000000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 6264700000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 25694500000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 4658000000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 85308900000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 231800000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 10709200000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 40989000000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1199400000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 4416800000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 5616200000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 20651700000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 68600000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 465911330.00
SCI.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 4.06
SCI.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1891600000.00
SCI.NS income_statement (quarterly, 2025-09-30) — EBIT: 2613900000.00
SCI.NS income_statement (quarterly, 2025-09-30) — EBITDA: 2613900000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 4000000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 74640800000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 2679500000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 473800000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 473800000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 1531600000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 110930500000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 238300000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1292700000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 21204800000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 22497500000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 6441700000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 601200000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 19356900000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Net Income: 1891600000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1891600000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1891600000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1891600000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 1891600000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1891600000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -473800000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -473800000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 74640800000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 85304900000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 2300000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 7600000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 2613900000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 1891600000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Operating Income: 1507400000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 13388700000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 465799010.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1579200000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1257500000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 80650900000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 4000000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1861100000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 800000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 972700000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1172100000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 74409000000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 16500000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 19429800000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Payables: 8622400000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 2140100000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 10709200000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 465799010.00
SCI.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 85308900000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 85304900000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
SCI.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 248500000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.12
SCI.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 129084500000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 106513700000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 28113700000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 85308900000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 11881300000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 43775600000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 88095500000.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 23123900000.00
SCI.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
SCI.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
SCI.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 20337300000.00
SCI.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 505800000.00
SCI.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 16116700000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 466018412.00
SCI.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 8.69
SCI.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 11543100000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 466018412.00
SCI.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 8.69
SCI.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 4049700000.00
SCI.NS income_statement (quarterly, 2025-12-31) — EBIT: 4753200000.00
SCI.NS income_statement (quarterly, 2025-12-31) — EBITDA: 4753200000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 4573600000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 483900000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 483900000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Net Income: 4049700000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 4049700000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 4049700000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 4049700000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 4049700000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 4049700000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -483900000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -483900000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 4753200000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 4049700000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Operating Income: 4067800000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 16116700000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 567800000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 505800000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
SCI.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 4269300000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 11543100000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
SCI.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
SCI.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 219600000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.05
SCI.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 12048900000.00
SCI.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
SCI.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
SCI.NS income_statement (annual, 2026-03-31) — +Operating Expense: 2403300000.00
SCI.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 621900000.00
SCI.NS income_statement (annual, 2026-03-31) — +Total Revenue: 57797900000.00
SCI.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 15132100000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 12110800000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 12110800000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 11923900000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 11923900000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 0.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 0.00
SCI.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 212600000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 212600000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 465592635.00
SCI.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 8.69
SCI.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1396400000.00
SCI.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -15504400000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 2023200000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 2023200000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 4658000000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4658000000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1148600000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1148600000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 31459400000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 31459400000.00
SCI.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -6087900000.00
SCI.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -809100000.00
SCI.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -14736900000.00
SCI.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 84200000.00
SCI.NS cash_flow (annual, 2026-03-31) — Change In Payable: 3501500000.00
SCI.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 656000000.00
SCI.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -11304300000.00
SCI.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -322600000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Common Stock: 4658000000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 4658000000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 90962900000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 90962900000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 49500000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 49500000.00
SCI.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 44178200000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 11262000000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Current Assets: 48108700000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 48108700000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 1315800000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1315800000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Current Debt: 5456300000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 5456300000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 6772100000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 6772100000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 21575600000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 21575600000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 105500000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 105500000.00
SCI.NS cash_flow (annual, 2026-03-31) — Depreciation: 10638300000.00
SCI.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 10638300000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 465592635.00
SCI.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 8.69
SCI.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 13529200000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 4046000000.00
SCI.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 373500000.00
SCI.NS income_statement (annual, 2026-03-31) — EBIT: 15962200000.00
SCI.NS income_statement (quarterly, 2026-03-31) — EBIT: 4627100000.00
SCI.NS income_statement (annual, 2026-03-31) — EBITDA: 26600500000.00
SCI.NS income_statement (quarterly, 2026-03-31) — EBITDA: 4627100000.00
SCI.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 74800000.00
SCI.NS cash_flow (annual, 2026-03-31) — End Cash Position: 1148600000.00
SCI.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -5179000000.00
SCI.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -2072300000.00
SCI.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -461700000.00
SCI.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -334200000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 4300000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 4300000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 72033500000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 72033500000.00
SCI.NS income_statement (annual, 2026-03-31) — Gross Profit: 13619700000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 3870100000.00
SCI.NS income_statement (annual, 2026-03-31) — Interest Expense: 1734100000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 471200000.00
SCI.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 1734100000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 471200000.00
SCI.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -1407200000.00
SCI.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 2963300000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Inventory: 2736700000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 2736700000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 115732200000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 115732200000.00
SCI.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -8575700000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 212600000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 212600000.00
SCI.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 7760000000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 707400000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 707400000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 19313000000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 19313000000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 20020400000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 20020400000.00
SCI.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 7760000000.00
SCI.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -4004000000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 6817400000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 6817400000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 612200000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 612200000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Net Debt: 23620700000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 23620700000.00
SCI.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 1268600000.00
SCI.NS income_statement (annual, 2026-03-31) — Net Income: 13529200000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Net Income: 4046000000.00
SCI.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 13529200000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 4046000000.00
SCI.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 13529200000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 4046000000.00
SCI.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 13529200000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 4046000000.00
SCI.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 13529200000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 4046000000.00
SCI.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 14228100000.00
SCI.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 13529200000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 4046000000.00
SCI.NS income_statement (annual, 2026-03-31) — Net Interest Income: -1734100000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -471200000.00
SCI.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 3048200000.00
SCI.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 3756000000.00
SCI.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 3756000000.00
SCI.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1734100000.00
SCI.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -471200000.00
SCI.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -185800000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Net PPE: 72033500000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 72033500000.00
SCI.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -14967600000.00
SCI.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 0.00
SCI.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 90958600000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 90958600000.00
SCI.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 2200000.00
SCI.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 2200000.00